scorecardresearch
Add as a preferred source on Google
Wednesday, April 8, 2026
TopicDilip Shanghvi

Topic: Dilip Shanghvi

Sun Pharmaceuticals undergoes SEBI-ordered forensic audit

The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.

Dilip Shanghvi of Sun Pharmaceutical’s to keep stake in Suzlon Energy despite falling value

In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.

On Camera

Rahul Gandhi wants to jail Himanta Sarma but Congress has a Bihar-sized problem in Assam

The Congress has promised Rs 50,000 assistance to each woman but as we've seen in many recent elections, voters seem to be conscious of the proverb: 'A bird in hand is worth two in the bush.'

Stocks fall, oil prices climb as Trump issues fresh threat to Iran ahead of his deadline

Fears that an escalation of the conflict could heighten a fuel squeeze & endanger the economy unnerved traders, with NYT reporting Iran stopped negotiating a truce with the US.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.